These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12584285)

  • 1. Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
    Bruun L; Björk T; Lilja H; Becker C; Gustafsson O; Christensson A
    Nephrol Dial Transplant; 2003 Mar; 18(3):598-603. PubMed ID: 12584285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?
    Djavan B; Shariat S; Ghawidel K; Güven-Marberger K; Remzi M; Kovarik J; Hoerl WH; Marberger M
    Urology; 1999 Jun; 53(6):1169-74. PubMed ID: 10367847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in percent free prostate-specific antigen in men with chronic kidney disease.
    Bruun L; Savage C; Cronin AM; Hugosson J; Lilja H; Christensson A
    Nephrol Dial Transplant; 2009 Apr; 24(4):1238-41. PubMed ID: 19028756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL.
    Okegawa T; Kinjo M; Ohta M; Miura I; Horie S; Nutahara K; Higashihara E
    Int J Urol; 2003 Apr; 10(4):201-6. PubMed ID: 12657099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis.
    Lein M; Jung K; Elgeti U; Petras T; Stephan C; Brux B; Sinha P; Winkelmann B; Schnorr D; Loening S
    Eur Urol; 2001 Jan; 39(1):57-64. PubMed ID: 11173940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of the various combinations of free, complexed, and total prostate-specific antigen for the detection of prostate cancer.
    Okegawa T; Noda H; Nutahara K; Higashihara E
    Eur Urol; 2000 Oct; 38(4):380-7. PubMed ID: 11025374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?
    Jung K; Elgeti U; Lein M; Brux B; Sinha P; Rudolph B; Hauptmann S; Schnorr D; Loening SA
    Clin Chem; 2000 Jan; 46(1):55-62. PubMed ID: 10620572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemodialysis on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoglu U
    Scand J Urol Nephrol; 2007; 41(5):382-6. PubMed ID: 17853041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen.
    Sokoll LJ; Bruzek DJ; Dua R; Dunn W; Mohr P; Wallerson G; Eisenberger M; Partin AW; Chan DW
    Urology; 2002 Oct; 60(4 Suppl 1):24-30. PubMed ID: 12384159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
    Naya Y; Stamey TA; Cheli CD; Partin AW; Sokoll LJ; Chan DW; Brawer MK; Taneja SS; Lepor H; Bartsch G; Childs S; Fritsche HA; Babaian RJ
    Urology; 2002 Oct; 60(4 Suppl 1):36-41. PubMed ID: 12384161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.
    Partin AW; Brawer MK; Bartsch G; Horninger W; Taneja SS; Lepor H; Babaian R; Childs SJ; Stamey T; Fritsche HA; Sokoll L; Chan DW; Thiel RP; Cheli CD
    J Urol; 2003 Nov; 170(5):1787-91. PubMed ID: 14532777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL.
    Okegawa T; Noda H; Nutahara K; Higashihara E
    Urology; 2000 May; 55(5):700-4. PubMed ID: 10792084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular forms of prostate-specific antigen in serum with concentrations of total prostate-specific antigen <4 microg/L: are they useful tools for early detection and screening of prostate cancer?
    Jung K; Stephan C; Elgeti U; Lein M; Brux B; Kristiansen G; Rudolph B; Hauptmann S; Schnorr D; Loening SA; Sinha P
    Int J Cancer; 2001 Sep; 93(5):759-65. PubMed ID: 11477592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.
    Naya Y; Fritsche HA; Cheli CD; Stamey TA; Bartsch G; Brawer MK; Childs S; Taneja SS; Lepor H; Partin AW; Sokoll LJ; Chan DW; Babaian RJ
    Urology; 2003 Dec; 62(6):1058-62. PubMed ID: 14665355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSA-related markers in the detection of prostate cancer and high-grade disease in the contemporary era with extended biopsy.
    Bratslavsky G; Fisher HA; Kaufman RP; Voskoboynik D; Nazeer T; Mian BM
    Urol Oncol; 2008; 26(2):166-70. PubMed ID: 18312936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prostatic massage on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoğlu U
    Urology; 2005 Dec; 66(6):1234-8. PubMed ID: 16360449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of various combinations of free, complexed and total prostate-specific antigen levels as predictors of the pathologic stage of prostate cancer.
    Okegawa T; Noda H; Ohta M; Kato M; Nutahara K; Higashihara E
    Int J Urol; 2001 Aug; 8(8):438-43. PubMed ID: 11555010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen in hemodialysis patients and the influence of dialysis in its levels.
    Tzanakis I; Kazoulis S; Girousis N; Kagia S; Spandidakis V; Karefillakis N; Georgila M; Cristoulakis I; Hatzilias P; Kallivretakis N
    Nephron; 2002 Feb; 90(2):230-3. PubMed ID: 11818714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific reference ranges for prostate-specific antigen (PSA) in Jordanian patients.
    Battikhi MN
    Prostate Cancer Prostatic Dis; 2003; 6(3):256-60. PubMed ID: 12970732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.